Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis
Open Access
- 3 November 2023
- journal article
- research article
- Published by Elsevier in JHEP Reports
- Vol. 6 (1) , 100958
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study designContemporary Clinical Trials, 2016
- Increase of infiltrating monocytes in the livers of patients with chronic liver diseases.2016
- The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseasesClinical and Translational Medicine, 2015
- A comparative encyclopedia of DNA elements in the mouse genomeNature, 2014
- Portal, but not lobular, macrophages express matrix metalloproteinase‐9: association with the ductular reaction and fibrosis in chronic hepatitis CLiver International, 2012
- Monocyte subsets in human liver disease show distinct phenotypic and functional characteristicsHepatology, 2012
- Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humansHepatology, 2012
- Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in miceJournal of Clinical Investigation, 2010
- CCR2 promotes hepatic fibrosis in mice #Hepatology, 2009
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005